Stockreport

Immix Biopharma to Present Abstract at the upcoming ASH 2025 Annual Meeting [Yahoo! Finance]

Immix Biopharma, Inc.  (IMMX) 
PDF global leader in relapsed/refractory AL Amyloidosis, today announced that it will present a NXC-201 abstract at the upcoming American Society of Hematology (ASH) 67 th A [Read more]